Improved stability and selectivity of lytic peptides through self-assembly

Biochemical and Biophysical Research Communications

Volumn 361, Issue 3, 2007, Pages 712-717

  Tu, Zhigang ^a   Hao, Jumin ^a   Kharidia, Riddhi ^a   Meng, Xiao G ^a   Liang, Jun F ^a  

^a Stevens Institute of Technology   (United States)

Author keywords

Anticancer; Enzyme resistance; Nanostructure; Peptide; Selectivity; Self assembly

Indexed keywords

GLUTAMYLGLUTAMYLASPARAGINYLPHENYLALANYLLEUCYLGLYCYLALANYL LEUCYLPHENYLALANYLLYSYLALANYLLEUCYLSERYLLYSYLLEUCYLLEUCINE; NANOMATERIAL; PEPTIDE; PHENYLALANYLLEUCYLGLYCYLALANYLLEUCYLPHENYLALANYLLYSYLALANYL LEUCYLSERYLLYSYLLEUCYLLEUCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL ACTIVITY; CONTROLLED STUDY; CYTOLYSIS; DRUG TARGETING; ENZYME DEGRADATION; FIBER; HUMAN; HUMAN CELL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN STABILITY; SUSTAINED DRUG RELEASE;

AMINO ACID SEQUENCE; CELLS, CULTURED; HUMANS; MICROSCOPY, ATOMIC FORCE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NANOSTRUCTURES; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY;

EID: 34547838255     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.178     Document Type: Article

References (20)

1. Hamman J.H., Enslin G.M., and Kotze A.F. Oral delivery of peptide drugs: barriers and developments. BioDrugs 19 (2005) 165-177
2. Sato A.K., Viswanathan M., Kent R.B., and Wood C.R. Therapeutic peptides: technological advances driving peptides into development. Curr. Opin. Biotechnol. 17 (2006) 638-642
3. Green B.D., Gault V.A., Mooney M.H., Irwin N., Harriott P., Greer B., Bailey C.J., O'Harte F.P., and Flatt P.R. Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues. Biol. Chem. 385 (2004) 169-177
4. Heck T., Limbach M., Geueke B., Zacharias M., Gardiner J., Kohler H.P., and Seebach D. Enzymatic degradation of beta- and mixed alpha,beta-oligopeptides. Chem. Biodivers. 3 (2006) 1325-1348
5. Janek K., Rothemund S., Gast K., Beyermann M., Zipper J., Fabian H., Bienert M., and Krause E. Study of the conformational transition of A beta(1-42) using d-amino acid replacement analogues. Biochemistry 40 (2001) 5457-5463
6. Li J., and Kao W.J. Synthesis of polyethylene glycol (PEG) derivatives and PEGylated-peptide biopolymer conjugates. Biomacromolecules 4 (2003) 055-067
7. Ricci M., Giovagnoli S., Blasi P., Schoubben A., Perioli L., and Rossi C. Development of liposomal capreomycin sulfate formulations: effects of formulation variables on peptide encapsulation. Int. J. Pharm. 311 (2006) 172-181
8. Ibrahim M.A., Ismail A., Fetouh M.I., and Gopferich A. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. J. Control. Release 106 (2005) 241-252
9. Wu Y., Zheng Q., Du J., Song Y., Wu B., and Guo X. Self-assembled IKVAV peptide nanofibers promote adherence of PC12 cells. J. Huazhong Univ. Sci. Technolog. Med. Sci. 26 (2006) 594-596
10. Gelain F., Bottai D., Vescovi A., and Zhang S. Designer self-assembling peptide nanofiber scaffolds for adult mouse neural stem cell 3-dimensional cultures. PLoS ONE 1 (2006) e119
11. Ramachandran S., and Yu Y.B. Related, peptide-based viscoelastic matrices for drug delivery and tissue repair. BioDrugs 20 (2006) 263-269
12. Nagai Y., Unsworth L.D., Koutsopoulos S., and Zhang S. Slow release of molecules in self-assembling peptide nanofiber scaffold. J. Control. Release 115 (2006) 18-25
13. Won H.K., Jung S.J., Kim H.E., Seo M.D., and Lee B.J. Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of Gaegurin 5. J. Biol. Chem. 279 (2004) 14784-14791
14. Schwarz G., Brandenburg J., Reich M., Burster T., Driessen C., and Kalbacher H. Characterization of legumain. Biol. Chem. 383 (2002) 1813-1816
15. Liang J.F., Yang V.C., and Vaynshteyn Y. The minimal functional sequence of protamine. Biochem. Biophys. Res. Commun. 336 (2005) 653-659
16. Liang J.F., and Akaike T. Role of metabolic intermediates in lipopolysaccharide/cytokine-mediated production of nitric oxide in isolated mouse hepatocytes. Biochem. Biophys. Res. Commun. 236 (1997) 379-382
17. Liang J.F., and Yang V.C. Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity. Bioorg. Med. Chem. Lett. 15 (2005) 5071-5075
18. Park Y.J., Liang J.F., Ko K.S., Kim S.W., and Yang V.C. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J. Gene. Med. 5 (2003) 700-711
19. Oren Z., and Shai Y. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Biochemistry 39 (2000) 6103-6114
20. Raghunand N., He X., van Sluis R., Mahoney B., Baggett B., Taylor C.W., Paine-Murrieta G., Roe D., Bhujwalla Z.M., and Gillies R.J. Enhancement of chemotherapy by manipulation of tumour pH. Br. J. Cancer 80 (1999) 1005-1011